Among the top stories in cardiology this week was the American Heart Association updating its definition of resistant hypertension and a study that found higher dairy intake may reduce the risk for CVD and mortality.
Other top stories included the FDA granting fast track designation to a medication for heart failure, a discussion on the role genetic risk scores could play in the primary prevention of coronary artery disease and the effectiveness of home BP monitoring in managing hypertension. - by Janel Miller
Higher dairy intake may lower CVD, mortality risks
More than two servings of dairy per day was associated with a lower risk for CVD and death, according to new data published in The Lancet. Read more.
American Heart Association updates definition of resistant hypertension,
addresses management in new scientific statement
The American Heart Association has released an updated scientific statement on resistant hypertension that focuses on changes to the definition, approaches to diagnosis and recommendations for treatment of the disease. Read more.
FDA grants fast track designation for heart failure with preserved ejection fraction medication
Ironwood Pharmaceuticals announced that praliciguat for the treatment of patients with heart failure with preserved ejection fraction has been granted fast track designation by the FDA. Read more.
Genetic risk score may reshape primary prevention
The time has come for the genetic risk score, which is simple to calculate and inexpensive to acquire, to play a larger role in primary prevention of coronary artery disease, an expert said at the European Society of Cardiology Congress. Read more.
Home BP monitoring effective in managing hypertension
The use of home BP monitoring may allow health care providers to reduce medications for patients with hypertension while simultaneously controlling the condition more effectively, according to findings presented at the American Heart Association’s Joint Hypertension Scientific Sessions. Read more.